Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Jammu: Two Nabbed For Assaulting Police Officer, Hunt On For Others
'Uddhav Thackeray Treats Everyone With Arrogance, Will Lose Mumbai Civic Polls': Maharashtra Minister Sanjay Shirsat
Three Hospitality Groups Win Bids To Build Luxury Eco-Friendly Tourism Resorts At The Andaman & Nicobar Islands
Messi GOAT India Tour: Narendra Modi Meeting Called Off Last Minute In Delhi
(With inputs from PTI)
